GSK at a glance

To pioneer HIV treatments in 1980 and leaders in ​HIV innovation

Investigational medicines in our​ oncology pipeline

Of our revenue growth in 2024 generated by specialty medicines

We have vaccines for more than two thirds (23/32) of vaccine preventable diseases identified by the WHO

Vaccine doses delivered each day

Vaccines in development

Our general medicines reach people in more than 100 countries

Of helping millions of people with respiratory conditions to breathe more easily

Of our sales in 2024 were generated by general medicines